Mavuto a Mankhwala Osokoneza Thanzi A Mylan

Ngati mukufufuza kafukufuku wa levothyroxine ndi mankhwala a liothyronine kuti muzitha kuchipatala, mungamve zafukufuku wa US Food and Drug Administration (FDA) ku Mylan. Mylan ndi amene amagwiritsa ntchito mankhwala osokoneza bongo, ndipo amagwiritsa ntchito generic levothyroxine ndi liothyronine, yotchedwa Cytomel . Mankhwalawa onse ndi mankhwala a chithokomiro othandizira kuti athetse vuto la hypothyroidism.

M'chaka cha 2009, a FDA adayambitsa kufufuza, koma patapita milungu ingapo, kufufuza kunatsekedwa, ndipo panalibenso umboni wakuti mankhwala a Mylan, kuphatikizapo levothyroxine, anakhudzidwa.

Nazi mfundo zomwe mukufuna kuti mudziwe kuti mudziwe bwino za mankhwalawa.

Chiyambi

Mu 2009, Mylan ku West Virginia adayang'aniridwa ndi bungwe la federal. Gawo la Pittsburgh Post linasintha nkhani ya ogwira ntchito ku plant of Mylan's West Virginia, omwe, malinga ndi malemba a mkati omwe apeza ndi Post-Gazette , "nthawi zonse amaposa machenjezo opangidwa ndi makompyuta onena za mavuto omwe amapezeka nawo."

Panthawiyo, a FDA amanena kuti Mylan ankachita nawo zinthu zabodza komanso kusintha zinthu, mwina kwa zaka ziwiri kapena kuposerapo. Dera la FDA litatsegula kafukufuku ku Mylan, kampaniyo inalengeza kuti chipani cha FDA chinali chizoloƔezi.

A FDA, komabe, adatenga njira yosavomerezeka yopereka chigamulo chotsutsa ndikutsutsa zomwe a Mylan anachita pofuna kuchepetsa kuopsa kofufuza.

Panthawi yomwe kufufuza kwachitika, Pittsburgh Post-Gazette inafotokoza mwatsatanetsatane mkhalidwe wa Mylan, kuphatikizapo nkhani zotsatirazi:

Pambuyo pa milungu ingapo zomwe Mylan anagulitsa mitengo yamtengo wapatali, ndipo Mylan ndi FDA adayambitsa nkhondo zapagulu. Mylan anatsutsanso olemba nkhani a Gazette Post omwe anathyola nkhaniyi kuti afotokozedwe.

The FDA potsiriza anachotsa Mylan, kulengeza pa August 13, 2009. Malinga ndi a FDA, Mylan anali atachita kafukufuku wochuluka, wolankhulana ndi bungwe la chipani, ndi a FDA anatseka kufufuza.

A Mylan akutsutsana ndi nyuzipepalayi inakhazikitsidwa mu 2012, ndipo Mylan ndi Post-Gazette adatulutsa mawu omwe akuti:

Mlanduwu watsimikiziridwa kuti akwaniritsidwe onse awiri. The Post-Gazette sanapeze ndipo sankafuna kunena kuti Mylan anali atapanga kapena kufalitsa mankhwala osokoneza bongo.

Mawu ochokera

Zomwe zinachitikira chithandizo cha chithokomiro chinali chakuti panalibenso umboni wosonyeza kuti mankhwala osokoneza bongo opangidwa ndi Mylan, kuphatikizapo mankhwala a levothyroxine ndi liothyronine omwe anthu ambiri ali ndi hypothyroidism, adakhudzidwa m'njira iliyonse.

Pa nthawi yomweyi, anthu omwe ali ndi hypothyroidism omwe amachititsa kachilombo koyambitsa mankhwala a levothyroxine ayenera kudziwa kuti madokotala ambiri sawalimbikitsa kuti chithokomiro chikhale ndi mankhwala enaake . Chifukwa chake n'chakuti mankhwala onse a levothyroxine, kuphatikizapo mankhwala omwe amachititsa kuti apange mankhwala komanso dzina lake, amaloledwa kukhala osiyana ndi 95 mpaka 105 peresenti ya mlingo woyenera. Mukatenga levothyroxine yowonjezera, zowonjezera zimatha kuchokera kuzipangizo zilizonse, zomwe zikutanthawuza kuti kubwezeretsa kwa mlingo uliwonse kumatha kugwera paliponse mkati mwazomwezo.

Ngakhale pang'ono kusiyana kwa potency kungalepheretse mphamvu yanu kutentha mahomoni m'malo.

Kukhazikitsa malo otsekemera a ma chithokomiro ndi ofunika kwambiri kwa opulumutsidwa a khansa ya chithokomiro, omwe angafune kuti nthawi zonse asamalire chithokomiro choyambitsa mahomoni (TSH) monga gawo la chithandizo chawo, ndi kupewa kuteteza khansa ya chithokomiro.

Ngati mukugwiritsa ntchito levothyroxine yowonjezera kuchokera kwa wojambula aliyense, zimathandiza kuti mukambirane za vuto lanu ndi wothandizira zaumoyo wanu, kuti mudziwe ngati mankhwalawa angakhale mankhwala abwino kwambiri.